Company Description: Aperture Therapeutics is a pre-clinical stage drug discovery company developing novel therapeutics to modulate neuroinflammation in age-related neurodegenerative disorders. The company has an innovative high-throughput drug discovery platform leveraging patient stem cell libraries that embraces genetic diversity of the patient population and disease-modifying protective gene variants that are associated with prolonged survival of patient subpopulations. The company has 3 therapeutic oligonucleotide programs at different stages of development.